Browsing: Ozempic
Pfizer stock surges 3% after activist Starboard takes $1 billion stake, taps former execs
A global pandemic propelled Pfizer’s stock to record highs after the company delivered the world’s first COVID-19 vaccine, but the…
Less than a year ago, the head of Novo Nordisk A/S was fielding calls from “scared” food industry executives about his company’s…
People with a history of opioid abuse who took Novo Nordisk A/S’s Ozempic were less likely to overdose, according to…
A rare issue unites Americans across the political divide: the nation’s broken healthcare system, which is slowly killing its citizens.…
Women Taking Mounjaro And Zepbound Lose More Weight Than Men, New Study Suggests: What To Know
Topline Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year lost…
At least two in five U.S. adults — or more than 57 million people – under the age of 65…
Ozempic, the highly popular GLP-1 agonist drug touted by many celebrities for weight loss, is in short supply, according to…
Mars, the snack conglomerate behind M&Ms and Snickers, may have finally satisfied its sweet tooth. The company will acquire Pringles-maker…
Exclusive: The COO of Hims & Hers was the third person to try their GLP-1 drugs—and she’s ready to share her story
Melissa Baird, a health care executive based in Seattle knows first-hand the stigma around weight at work. “I struggled with…
InnovationRx is your weekly digest of healthcare news. To get it in your inbox, subscribe here. Venture capital funding reached…